We are driving innovation with industry and manufacturing partners to transform industries and deliver growth to our economies, thereby helping to improve people’s livelihoods.
We are improving the health of people across the world through new discoveries, treatments and patient pathways and working in partnership to build a transformative health ecosystem in our region.
We are working to understand the impact of climate change on the planet and its people, to improve air quality, and developing new technologies to decarbonise energy and transport in partnership with industry and government.
We are working with our partners to tackle inequalities in all aspects of society, striving to make change for a fairer world and one in which people can enjoy a fulfilling, rewarding life.
We explore what it means to be human – in historical and cultural contexts, within ethical and legal norms and through languages and communication.
From atoms to astronomy, computers to cars and robots to robust materials, our goal is to transform our understanding of the world to make life easier, healthier and more sustainable.
Across the breadth of life and environmental sciences, we discover, apply and translate science to forge major advances in human and environmental health.
With more than 1,000 academic staff researchers and around £80 million new research funding per year, we are dedicated to performing world-leading research with the ultimate goal of improving human health.
We address the challenges facing society and the economy, from shedding light on the refugee crisis, to character education in schools, through to developing leaders in the NHS.
Cancer Research UK Clinical Trials Unit (CRCTU) has a presence in nearly 400 sites in over 20 countries delivering its vision for innovative and efficient trials to meet the needs of patients in the modern era of multi-modality and multiomic therapeutics.
Our full portfolio of trials.
CRCTU welcomes applications to collaborate with us.
Our new Clinical Trials MSc covers the theoretical and practical aspects of the design, conduct, analysis and interpretation of clinical trials.
06 February 2018
Changes have been recommended to international guidelines used in the development of clinical trials in an effort to gain information about the impact of the treatment on participating patients and their quality of life.
01 February 2018
A patient who was given only 12 months to live four years ago has teamed up with his consultant to help launch a national campaign for Cancer Research UK.
29 January 2018
A new nanopore technology for direct sequencing of long strands of DNA has resulted in the most complete human genome ever assembled with a single technology, scientists have revealed.
24 November 2017
A trial designed and co-ordinated by the Cancer Research UK Clinical Trials Unit to test an experimental drug in patients with head and neck cancer has launched today through the Combinations Alliance.
02 November 2017
Cancer Research UK has awarded the University of Birmingham £1.5 million to fund a five-year research programme aimed at finding new treatments for bowel cancer.
10 October 2017
The University of Birmingham's iconic clock tower 'Old Joe' is turning pink to mark October as Breast Cancer Awareness month.
27 September 2017
A genetic fault has been identified in people with an aggressive type of leukaemia that can significantly affect how they respond to treatment.
25 September 2017
GPs can be reluctant to refer patients with symptoms of bowel cancer for further investigations, a study by the Universities of Birmingham and Exeter has found.
16 September 2017
Research led by the University of Birmingham shows more precisely how G protein-coupled receptors are the key target of a large number of drugs.
12 September 2017
A scientist at the University of Birmingham has received a £1.4 million award from Cancer Research UK to carry out pioneering research.
Lung cancer survivors who quit smoking within a year of diagnosis will live for longer than those who continue to smoke, according to new research led by the Universities of Birmingham and Oxford.
26 June 2017
Cancer tumours manipulate a natural cell process to promote their survival suggesting that controlling this mechanism could stop progression of the disease.
View all news